D. Bryder, D. J. Rossi, and I. L. Weissman, Hematopoietic Stem Cells, The American Journal of Pathology, vol.169, issue.2, pp.338-346060312, 2006.
DOI : 10.2353/ajpath.2006.060312

R. M. Bukowski, G. T. Budd, J. A. Gibbons, R. J. Bauer, A. Childs et al., Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effects., Journal of Clinical Oncology, vol.12, issue.1, pp.97-106, 1994.
DOI : 10.1200/JCO.1994.12.1.97

C. Cheers, A. M. Haigh, A. Kelso, D. Metcalf, E. R. Stanley et al., Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage- , and multi-CSFs, Infect. Immun, vol.56, pp.247-251, 1988.

G. De-haan, B. Dontje, C. Engel, M. Loeffler, and W. Nijhof, The kinetics of murine hematopoietic stem cells in vivo in response to prolonged increased mature blood cell production induced by granulocyte colony-stimulating factor, Blood, vol.86, pp.2986-2992, 1995.

A. Dekker, S. Bulley, J. Beyene, L. L. Dupuis, J. J. Doyle et al., Meta-Analysis of Randomized Controlled Trials of Prophylactic Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor After Autologous and Allogeneic Stem Cell Transplantation, Journal of Clinical Oncology, vol.24, issue.33, pp.5207-5215, 2006.
DOI : 10.1200/JCO.2006.06.1663

D. Santa, F. , V. Narang, Z. H. Yap, B. K. Tusi et al., Jmjd3 contributes to the control of gene expression in LPS-activated macrophages, The EMBO Journal, vol.447, issue.21, pp.3341-3352271, 2009.
DOI : 10.1128/MCB.00788-06

M. B. Garnick and J. B. Stoudemire, Preclinical and clinical evaluation of recombinant human macrophage colony-stimulating factor (rhM-CSF) Int, 1990.

C. Giraud, C. S. Bernard, V. Calderon, L. Yang, A. Filloux et al., The PprA-PprB two-component system activates CupE, the first non-archetypal Pseudomonas aeruginosa chaperone-usher pathway system assembling fimbriae, Environmental Microbiology, vol.34, issue.3, pp.666-683, 2011.
DOI : 10.1111/j.1574-6976.2009.00201.x
URL : https://hal.archives-ouvertes.fr/hal-00557837

J. A. Hamilton and A. Achuthan, Colony stimulating factors and myeloid cell biology in health and disease, Trends in Immunology, vol.34, issue.2, pp.81-89, 2013.
DOI : 10.1016/j.it.2012.08.006

D. Hashimoto, A. Chow, M. Greter, Y. Saenger, W. H. Kwan et al., Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation, The Journal of Experimental Medicine, vol.92, issue.5, pp.1069-1082, 2011.
DOI : 10.4049/jimmunol.169.12.7111
URL : http://jem.rupress.org/content/jem/208/5/1069.full.pdf

M. Heuser, A. Ganser, and C. Bokemeyer, National Comprehensive Cancer Network, and European Organization for Research and Treatment of Cancer Use of colony-stimulating factors for chemotherapy-associated neutropenia: review of current 2279, 2007.

D. A. Hume and K. P. Macdonald, Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling, Blood, vol.119, issue.8, pp.1810-1820, 2012.
DOI : 10.1182/blood-2011-09-379214

F. Kimura, K. Sato, H. Akiyama, H. Sao, S. Okamoto et al., M-CSF attenuates severity of chronic GVHD after unrelated BMT, Bone Marrow Transplantation, vol.11, issue.3, pp.426-429
DOI : 10.1016/j.bbmt.2005.09.004

K. Y. King and M. A. , Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response, Nature Reviews Immunology, vol.111, issue.10, pp.685-692, 2011.
DOI : 10.1182/blood-2007-09-115006

B. Koch, L. E. Jensen, and O. Nybroe, A panel of Tn7-based vectors for insertion of the gfp marker gene or for delivery of cloned DNA into Gram-negative bacteria at a neutral chromosomal site, Journal of Microbiological Methods, vol.45, issue.3, pp.187-195, 2001.
DOI : 10.1016/S0167-7012(01)00246-9

J. P. Latgé, Aspergillus fumigatus and aspergillosis, Clin. Microbiol. Rev, vol.12, pp.310-350, 1999.
DOI : 10.1128/9781555815523

M. G. Manz and S. Boettcher, Emergency granulopoiesis, Nature Reviews Immunology, vol.367, issue.5, pp.302-314, 2014.
DOI : 10.1056/NEJMoa1200710

D. Metcalf, Hematopoietic cytokines, Blood, vol.111, issue.2, pp.485-491, 2008.
DOI : 10.1182/blood-2007-03-079681
URL : http://www.bloodjournal.org/content/bloodjournal/111/2/485.full.pdf

C. Mirantes, E. Passegué, and E. M. Pietras, Pro-inflammatory cytokines: Emerging players regulating HSC function in normal and diseased hematopoiesis, Experimental Cell Research, vol.329, issue.2, pp.248-254, 2014.
DOI : 10.1016/j.yexcr.2014.08.017

N. Mossadegh-keller, S. Sarrazin, P. K. Kandalla, L. Espinosa, E. R. Stanley et al., M-CSF instructs myeloid lineage fate in single haematopoietic stem cells, Nature, vol.504, issue.7448, pp.239-243, 2013.
DOI : 10.1016/B978-0-12-391857-4.00009-4

D. H. Munn, M. B. Garnick, and N. K. Cheung, Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates, Blood, vol.75, pp.2042-2048, 1990.

J. Nemunaitis, K. Shannon-dorcy, F. R. Appelbaum, J. Meyers, A. Owens et al., Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor, Blood, vol.82, pp.1422-1427, 1993.

F. J. Pixley and E. R. Stanley, CSF-1 regulation of the wandering macrophage: complexity in action, Trends in Cell Biology, vol.14, issue.11, pp.628-638, 2004.
DOI : 10.1016/j.tcb.2004.09.016

S. Sarrazin and M. Sieweke, Integration of cytokine and transcription factor signals in hematopoietic stem cell commitment, Seminars in Immunology, vol.23, issue.5, pp.326-334, 2011.
DOI : 10.1016/j.smim.2011.08.011
URL : https://hal.archives-ouvertes.fr/hal-00674515

S. Sarrazin, N. Mossadegh-keller, T. Fukao, A. Aziz, F. Mourcin et al., MafB Restricts M-CSF-Dependent Myeloid Commitment Divisions of Hematopoietic Stem Cells, Cell, vol.138, issue.2, pp.300-313, 2009.
DOI : 10.1016/j.cell.2009.04.057
URL : https://hal.archives-ouvertes.fr/inserm-00420157

L. G. Schuettpelz, J. N. Borgerding, M. J. Christopher, P. K. Gopalan, M. P. Romine et al., G-CSF regulates hematopoietic stem cell activity, in part, through activation of Toll-like receptor signaling, Leukemia, vol.19, issue.9, pp.1851-1860, 2014.
DOI : 10.1097/MOH.0b013e32835903ab

L. Sung, P. C. Nathan, S. M. Alibhai, G. A. Tomlinson, and J. Beyene, Meta-analysis: Effect of Prophylactic Hematopoietic Colony-Stimulating Factors on Mortality and Outcomes of Infection, Annals of Internal Medicine, vol.147, issue.6, pp.400-411, 2007.
DOI : 10.7326/0003-4819-147-6-200709180-00010

L. B. To, D. N. Haylock, P. J. Simmons, and C. A. Juttner, The biology and clinical uses of blood stem cells, Blood, vol.89, pp.2233-2258, 1997.

M. Tomblyn, T. Chiller, H. Einsele, R. Gress, K. Sepkowitz et al., Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective, Biology of Blood and Marrow Transplantation, vol.15, issue.10, pp.1143-1238, 2009.
DOI : 10.1016/j.bbmt.2009.06.019

L. Wan, Y. Zhang, Y. Lai, M. Jiang, Y. Song et al., Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Prevention and Treatment of Invasive Fungal Disease in Recipients of Allogeneic Stem-Cell Transplantation: A Prospective Multicenter Randomized Phase IV Trial, Journal of Clinical Oncology, vol.33, issue.34, pp.3999-4006, 2015.
DOI : 10.1200/JCO.2014.60.5121

I. G. Winkler, A. R. Pettit, L. J. Raggatt, R. N. Jacobsen, C. E. Forristal et al., Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation, Leukemia, vol.181, issue.7, pp.1594-1601, 2012.
DOI : 10.1016/j.cell.2004.07.004

J. L. Zhao and D. Baltimore, Regulation of stress-induced hematopoiesis, Current Opinion in Hematology, vol.22, pp.286-292, 2015.
DOI : 10.1097/MOH.0000000000000149